200 related articles for article (PubMed ID: 2691308)
1. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
de Bruijne JW; Snel P; Lamers CB
Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole in the treatment of duodenal ulcer.
Bianchi Porro G; Parente F
Scand J Gastroenterol Suppl; 1989; 166():48-53; discussion 74-5. PubMed ID: 2557670
[TBL] [Abstract][Full Text] [Related]
5. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility and safety of omeprazole.
Walan A
Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole in the acute treatment of gastric ulcer.
Schepp W; Classen M
Scand J Gastroenterol Suppl; 1989; 166():58-62; discussion 74-5. PubMed ID: 2690333
[TBL] [Abstract][Full Text] [Related]
9. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
11. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.
Delchier JC; Isal JP; Eriksson S; Soule JC
Gut; 1989 Sep; 30(9):1173-8. PubMed ID: 2680793
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
13. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
[TBL] [Abstract][Full Text] [Related]
14. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group.
BMJ; 1989 Mar; 298(6674):645-7. PubMed ID: 2496791
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
Young MD; Lottes SR; Webb LA
Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with omeprazole: assessment of efficacy and safety.
Walan A
J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
[TBL] [Abstract][Full Text] [Related]
19. Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors.
Walan A
Scand J Gastroenterol Suppl; 1986; 125():50-4. PubMed ID: 3029857
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole compared with ranitidine once daily in the treatment of duodenal ulcer.
Chelvam P; Goh KL; Leong YP; Leela MP; Yin TP; Ahmad H; Jalleh R; Wong NW; Lee HB; Mahendran T
J Gastroenterol Hepatol; 1989; 4 Suppl 2():53-61. PubMed ID: 2491362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
